Drivers and Roadblocks for GenAI Adoption in the Life Science Industry

Drivers and Roadblocks for GenAI Adoption in the Life Science Industry

This IDC Perspective reviews some of the key drivers and roadblocks for generative AI (GenAI) adoption in the life science industry and provides advice to technology buyers from the life science industry to help them make strategic decisions on their life science GenAI road map."While there are several drivers and roadblocks impacting the adoption of GenAI, the reality is that GenAI will disrupt and transform the life science industry. Fast adopters (that build in the necessary guardrails to ensure patient safety and regulatory compliance) will become leaders. GenAI has brought about the democratization of AI, and it will be incumbent upon executive leadership to make this technology accessible to all of its stakeholders, including employees, patients, and providers; build GenAI expertise within the organization; and drive an openness to adopt and adapt to the GenAI revolution that is reshaping the life science industry," said Dr. Nimita Limaye, research VP, Life Sciences R&D Strategy and Technology at IDC.

Please Note: Extended description available upon request.